ArticleFrontiers in immunology2022

Case Report: Dual Inhibition of HDAC and BTK for Diffuse Large B-Cell Lymphoma After Failure to CD19-Targeted CAR-T Therapy.

Weiguo Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.